Indiana University School of Medicine distinguished professor Debomoy Lahiri, PhD, has been named a 2022 fellow of the National Academy of Inventors – the highest professional distinction awarded to academic inventors.
Researchers from Indiana University School of Medicine and the University of Toronto have been awarded a five-year, $3.5 million grant from the National Institute on Aging (NIA) to identify new neurodegenerative disorders that are often misdiagnosed as other conditions.
Researchers from an Indiana University School of Medicine-led consortium of Alzheimer’s disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential therapeutic for Alzheimer’s disease.
Researchers from Indiana University School of Medicine have identified a protein that interacts and enhances the spread of neurotoxic species of tau—which is primarily found in neurons that appear abnormal in the brains of Alzheimer’s disease patients.
The second largest federally funded research program at Indiana University School of Medicine will receive $48.8 million over the next five years, fueling the work of researchers as they seek to discover treatments for Alzheimer’s disease.
Most drugs developed to treat Alzheimer’s disease have for years been ineffective in clinical trials. Researchers from Indiana University School of Medicine recently evaluated the efficacy of a failed clinical trial drug using their rigorous pipeline.
An Indiana University School of Medicine-Evansville faculty member has received a grant from the Alzheimer’s Association for new research to enhance detection of cortical atrophy in patients diagnosed with Alzheimer's disease.
Some patients in Indiana are now able to receive new screenings for early detection of Alzheimer’s disease thanks to a pilot program at Indiana University School of Medicine and Indiana University Health.